OncoSec Medical Incorporated ONCS

DigitalData Premium

All, I mean you can't tell me this isnt a textbook double bottom if this was on 5M its a buy. Crazy on a weekly chart. Would be a huge long position and wouild have to hold. Interesting. If this bottom holds here might actually buy and hold some just to see if we can get a 3-4 PT hit.

LadyAmalthea12 Premium

🟢 $ONCS Target 6.1 for 30.44% Or double position at 3.29 — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first...

Rocky88888888888 Premium

$ONCS BULLISH CYPHER PATTERN Strongest Wyckoff Re-accumulation with uprise, Influx of Strong Volume by MMs, setting up for becoming Parabolic Consolidation above upper resistance levels OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack...

LadyAmalthea12 Premium

🟢 $ONCS Target 6.17 for 30.44% Or double position at 3.29 Freakin' Finally... Looks like some nice upward potential from here... target is the same... — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from...

RNGezzus Pro+

BUY

KozakHlib Premium

Pupm&Dump trading strategy idea. $DTST is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $3,98; stop-loss — $4,46; take-profit — $3,02. Do not view this idea as a recommendation for trading or investing. It is...

LadyAmalthea12 Premium

$ONCS Target 7.20 for 25% Or next add level is at 4.32 — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first before you...

LadyAmalthea12 Premium

$ONCS Target 7.56 for 23.53% Or next add level is at 4.68 — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first before...

LadyAmalthea12 Premium

$ONCS Target 7.89 for 21.01% Or next add level is at 5.19 I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I...

Master_of_Fine_Charts Premium

I like the MACD crossing and the break of the descending trendline. I want to see the price break $5.75 with some volume to enter for a swing trade. $6.54 target

KozakHlib Premium

Contextual immersion trading strategy idea. OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in...

altinAdam Pro+

Pls see chart. Good luck. Notes: 130 mln market cap 27mln shares outstanding OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an...

altinAdam Pro+

Pls see chart. Trade safe.

AlenCiken

OncoSec's Novel COVID-19 Vaccine Candidate Featured in 'Straight Talk' Program by NBC TV in Portland, Oregon OncoSec and researchers at Providence Cancer Institute previously announced a collaboration to conduct a first-in-human trial of OncoSec's CORVax12 vaccine candidate. Providence has filed an Investigator-Initiated Investigational New Drug (IND)...

19:58

Gann-Mode Pro+

A quick video on Multi time-frame analysis and of how it help give us more confidence in the lower time-frames, where we will make our entries and exits. Happy trading guys! 👍

mauretto432

ONCS = RICAPITALIZATION = CINA TURNAMNET TAVO = MONSTER ALLERT TOO = PAY ATTENTION THE TIME ON MONSTER TURNOVER IS NEAR ....

PennyStock101 Premium

*******POSSIBLE BREAKOUT IN BIO STOCK WITH NICE PRICE ACTION, INCREASED INTEREST AMONG TRADERS AS RUMORS AND SPECULATION FOLLOW THIS STOCK, KEEP ON WATCHLIST FOR A RAPID MOVE*************** AVERAGE ANALYSTS PRICE TARGET $9 AVERAGE ANALYSTS RECOMMENDATION BUY COMPANY PROFILE OncoSec Medical, Inc. is a biotechnology company, which engages in...

mauretto432

When, I say that passion goes beyond the imagination, I am led back to this title, believe me, in many years of studies and research in the field of biotechnology, there have been many satisfactions compared to dispaires. Well if I told you that ONCS, in the second half of 2019 and in the first three months of 2020, will officially present TAVO to the world as a...